1 Market Overview

1.1 Product Overview and Scope of Biologic Medication in COVID-19

1.2 Classification of Biologic Medication in COVID-19 by Type

1.2.1 Overview: Global Biologic Medication in COVID-19 Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Biologic Medication in COVID-19 Revenue Market Share by Type in 2021

1.2.3 Neutralizing Antibodies

1.2.4 Anti-inflammatory Drugs

1.3 Global Biologic Medication in COVID-19 Market by Application

1.3.1 Overview: Global Biologic Medication in COVID-19 Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 COVID-19

1.3.3 Influenza

1.3.4 Malaria

1.3.5 Others

1.4 Global Biologic Medication in COVID-19 Market Size & Forecast

1.5 Global Biologic Medication in COVID-19 Market Size and Forecast by Region

1.5.1 Global Biologic Medication in COVID-19 Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Biologic Medication in COVID-19 Market Size by Region, (2017-2022)

1.5.3 North America Biologic Medication in COVID-19 Market Size and Prospect (2017-2028)

1.5.4 Europe Biologic Medication in COVID-19 Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Biologic Medication in COVID-19 Market Size and Prospect (2017-2028)

1.5.6 South America Biologic Medication in COVID-19 Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Biologic Medication in COVID-19 Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Biologic Medication in COVID-19 Market Drivers

1.6.2 Biologic Medication in COVID-19 Market Restraints

1.6.3 Biologic Medication in COVID-19 Trends Analysis

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche Biologic Medication in COVID-19 Product and Solutions

2.1.4 Roche Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Roche Recent Developments and Future Plans

2.2 Sanofi

2.2.1 Sanofi Details

2.2.2 Sanofi Major Business

2.2.3 Sanofi Biologic Medication in COVID-19 Product and Solutions

2.2.4 Sanofi Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Sanofi Recent Developments and Future Plans

2.3 Novartis

2.3.1 Novartis Details

2.3.2 Novartis Major Business

2.3.3 Novartis Biologic Medication in COVID-19 Product and Solutions

2.3.4 Novartis Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Novartis Recent Developments and Future Plans

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business

2.4.3 Merck Biologic Medication in COVID-19 Product and Solutions

2.4.4 Merck Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Merck Recent Developments and Future Plans

2.5 Bayer

2.5.1 Bayer Details

2.5.2 Bayer Major Business

2.5.3 Bayer Biologic Medication in COVID-19 Product and Solutions

2.5.4 Bayer Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Bayer Recent Developments and Future Plans

2.6 Shutaishen

2.6.1 Shutaishen Details

2.6.2 Shutaishen Major Business

2.6.3 Shutaishen Biologic Medication in COVID-19 Product and Solutions

2.6.4 Shutaishen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Shutaishen Recent Developments and Future Plans

2.7 Biogen

2.7.1 Biogen Details

2.7.2 Biogen Major Business

2.7.3 Biogen Biologic Medication in COVID-19 Product and Solutions

2.7.4 Biogen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Biogen Recent Developments and Future Plans

2.8 Regeneron Pharmaceuticals

2.8.1 Regeneron Pharmaceuticals Details

2.8.2 Regeneron Pharmaceuticals Major Business

2.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product and Solutions

2.8.4 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Regeneron Pharmaceuticals Recent Developments and Future Plans

2.9 Vir Biotech

2.9.1 Vir Biotech Details

2.9.2 Vir Biotech Major Business

2.9.3 Vir Biotech Biologic Medication in COVID-19 Product and Solutions

2.9.4 Vir Biotech Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Vir Biotech Recent Developments and Future Plans

2.10 Junshi Biosciences

2.10.1 Junshi Biosciences Details

2.10.2 Junshi Biosciences Major Business

2.10.3 Junshi Biosciences Biologic Medication in COVID-19 Product and Solutions

2.10.4 Junshi Biosciences Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Junshi Biosciences Recent Developments and Future Plans

2.11 Anke Biotechnology

2.11.1 Anke Biotechnology Details

2.11.2 Anke Biotechnology Major Business

2.11.3 Anke Biotechnology Biologic Medication in COVID-19 Product and Solutions

2.11.4 Anke Biotechnology Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Anke Biotechnology Recent Developments and Future Plans

2.12 OncoImmune

2.12.1 OncoImmune Details

2.12.2 OncoImmune Major Business

2.12.3 OncoImmune Biologic Medication in COVID-19 Product and Solutions

2.12.4 OncoImmune Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 OncoImmune Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Biologic Medication in COVID-19 Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Biologic Medication in COVID-19 Players Market Share in 2021

3.2.2 Top 10 Biologic Medication in COVID-19 Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Biologic Medication in COVID-19 Players Head Office, Products and Services Provided

3.4 Biologic Medication in COVID-19 Mergers & Acquisitions

3.5 Biologic Medication in COVID-19 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Biologic Medication in COVID-19 Revenue and Market Share by Type (2017-2022)

4.2 Global Biologic Medication in COVID-19 Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Biologic Medication in COVID-19 Revenue Market Share by Application (2017-2022)

5.2 Global Biologic Medication in COVID-19 Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Biologic Medication in COVID-19 Revenue by Type (2017-2028)

6.2 North America Biologic Medication in COVID-19 Revenue by Application (2017-2028)

6.3 North America Biologic Medication in COVID-19 Market Size by Country

6.3.1 North America Biologic Medication in COVID-19 Revenue by Country (2017-2028)

6.3.2 United States Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

6.3.3 Canada Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

6.3.4 Mexico Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Biologic Medication in COVID-19 Revenue by Type (2017-2028)

7.2 Europe Biologic Medication in COVID-19 Revenue by Application (2017-2028)

7.3 Europe Biologic Medication in COVID-19 Market Size by Country

7.3.1 Europe Biologic Medication in COVID-19 Revenue by Country (2017-2028)

7.3.2 Germany Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

7.3.3 France Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

7.3.5 Russia Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

7.3.6 Italy Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Biologic Medication in COVID-19 Revenue by Type (2017-2028)

8.2 Asia-Pacific Biologic Medication in COVID-19 Revenue by Application (2017-2028)

8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region

8.3.1 Asia-Pacific Biologic Medication in COVID-19 Revenue by Region (2017-2028)

8.3.2 China Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

8.3.3 Japan Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

8.3.4 South Korea Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

8.3.5 India Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

8.3.7 Australia Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Biologic Medication in COVID-19 Revenue by Type (2017-2028)

9.2 South America Biologic Medication in COVID-19 Revenue by Application (2017-2028)

9.3 South America Biologic Medication in COVID-19 Market Size by Country

9.3.1 South America Biologic Medication in COVID-19 Revenue by Country (2017-2028)

9.3.2 Brazil Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

9.3.3 Argentina Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Biologic Medication in COVID-19 Revenue by Type (2017-2028)

10.2 Middle East & Africa Biologic Medication in COVID-19 Revenue by Application (2017-2028)

10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country

10.3.1 Middle East & Africa Biologic Medication in COVID-19 Revenue by Country (2017-2028)

10.3.2 Turkey Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

10.3.4 UAE Biologic Medication in COVID-19 Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Biologic Medication in COVID-19 Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Biologic Medication in COVID-19 Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Biologic Medication in COVID-19 Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Biologic Medication in COVID-19 Revenue (USD Million) by Region (2017-2022)

Table 5. Global Biologic Medication in COVID-19 Revenue Market Share by Region (2023-2028)

Table 6. Roche Corporate Information, Head Office, and Major Competitors

Table 7. Roche Major Business

Table 8. Roche Biologic Medication in COVID-19 Product and Solutions

Table 9. Roche Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Sanofi Corporate Information, Head Office, and Major Competitors

Table 11. Sanofi Major Business

Table 12. Sanofi Biologic Medication in COVID-19 Product and Solutions

Table 13. Sanofi Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Novartis Corporate Information, Head Office, and Major Competitors

Table 15. Novartis Major Business

Table 16. Novartis Biologic Medication in COVID-19 Product and Solutions

Table 17. Novartis Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Merck Corporate Information, Head Office, and Major Competitors

Table 19. Merck Major Business

Table 20. Merck Biologic Medication in COVID-19 Product and Solutions

Table 21. Merck Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Bayer Corporate Information, Head Office, and Major Competitors

Table 23. Bayer Major Business

Table 24. Bayer Biologic Medication in COVID-19 Product and Solutions

Table 25. Bayer Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Shutaishen Corporate Information, Head Office, and Major Competitors

Table 27. Shutaishen Major Business

Table 28. Shutaishen Biologic Medication in COVID-19 Product and Solutions

Table 29. Shutaishen Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Biogen Corporate Information, Head Office, and Major Competitors

Table 31. Biogen Major Business

Table 32. Biogen Biologic Medication in COVID-19 Product and Solutions

Table 33. Biogen Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 35. Regeneron Pharmaceuticals Major Business

Table 36. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product and Solutions

Table 37. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Vir Biotech Corporate Information, Head Office, and Major Competitors

Table 39. Vir Biotech Major Business

Table 40. Vir Biotech Biologic Medication in COVID-19 Product and Solutions

Table 41. Vir Biotech Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Junshi Biosciences Corporate Information, Head Office, and Major Competitors

Table 43. Junshi Biosciences Major Business

Table 44. Junshi Biosciences Biologic Medication in COVID-19 Product and Solutions

Table 45. Junshi Biosciences Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Anke Biotechnology Corporate Information, Head Office, and Major Competitors

Table 47. Anke Biotechnology Major Business

Table 48. Anke Biotechnology Biologic Medication in COVID-19 Product and Solutions

Table 49. Anke Biotechnology Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. OncoImmune Corporate Information, Head Office, and Major Competitors

Table 51. OncoImmune Major Business

Table 52. OncoImmune Biologic Medication in COVID-19 Product and Solutions

Table 53. OncoImmune Biologic Medication in COVID-19 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Global Biologic Medication in COVID-19 Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 55. Global Biologic Medication in COVID-19 Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 56. Breakdown of Biologic Medication in COVID-19 by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Biologic Medication in COVID-19 Players Head Office, Products and Services Provided

Table 58. Biologic Medication in COVID-19 Mergers & Acquisitions in the Past Five Years

Table 59. Biologic Medication in COVID-19 New Entrants and Expansion Plans

Table 60. Global Biologic Medication in COVID-19 Revenue (USD Million) by Type (2017-2022)

Table 61. Global Biologic Medication in COVID-19 Revenue Share by Type (2017-2022)

Table 62. Global Biologic Medication in COVID-19 Revenue Forecast by Type (2023-2028)

Table 63. Global Biologic Medication in COVID-19 Revenue by Application (2017-2022)

Table 64. Global Biologic Medication in COVID-19 Revenue Forecast by Application (2023-2028)

Table 65. North America Biologic Medication in COVID-19 Revenue by Type (2017-2022) & (USD Million)

Table 66. North America Biologic Medication in COVID-19 Revenue by Type (2023-2028) & (USD Million)

Table 67. North America Biologic Medication in COVID-19 Revenue by Application (2017-2022) & (USD Million)

Table 68. North America Biologic Medication in COVID-19 Revenue by Application (2023-2028) & (USD Million)

Table 69. North America Biologic Medication in COVID-19 Revenue by Country (2017-2022) & (USD Million)

Table 70. North America Biologic Medication in COVID-19 Revenue by Country (2023-2028) & (USD Million)

Table 71. Europe Biologic Medication in COVID-19 Revenue by Type (2017-2022) & (USD Million)

Table 72. Europe Biologic Medication in COVID-19 Revenue by Type (2023-2028) & (USD Million)

Table 73. Europe Biologic Medication in COVID-19 Revenue by Application (2017-2022) & (USD Million)

Table 74. Europe Biologic Medication in COVID-19 Revenue by Application (2023-2028) & (USD Million)

Table 75. Europe Biologic Medication in COVID-19 Revenue by Country (2017-2022) & (USD Million)

Table 76. Europe Biologic Medication in COVID-19 Revenue by Country (2023-2028) & (USD Million)

Table 77. Asia-Pacific Biologic Medication in COVID-19 Revenue by Type (2017-2022) & (USD Million)

Table 78. Asia-Pacific Biologic Medication in COVID-19 Revenue by Type (2023-2028) & (USD Million)

Table 79. Asia-Pacific Biologic Medication in COVID-19 Revenue by Application (2017-2022) & (USD Million)

Table 80. Asia-Pacific Biologic Medication in COVID-19 Revenue by Application (2023-2028) & (USD Million)

Table 81. Asia-Pacific Biologic Medication in COVID-19 Revenue by Region (2017-2022) & (USD Million)

Table 82. Asia-Pacific Biologic Medication in COVID-19 Revenue by Region (2023-2028) & (USD Million)

Table 83. South America Biologic Medication in COVID-19 Revenue by Type (2017-2022) & (USD Million)

Table 84. South America Biologic Medication in COVID-19 Revenue by Type (2023-2028) & (USD Million)

Table 85. South America Biologic Medication in COVID-19 Revenue by Application (2017-2022) & (USD Million)

Table 86. South America Biologic Medication in COVID-19 Revenue by Application (2023-2028) & (USD Million)

Table 87. South America Biologic Medication in COVID-19 Revenue by Country (2017-2022) & (USD Million)

Table 88. South America Biologic Medication in COVID-19 Revenue by Country (2023-2028) & (USD Million)

Table 89. Middle East & Africa Biologic Medication in COVID-19 Revenue by Type (2017-2022) & (USD Million)

Table 90. Middle East & Africa Biologic Medication in COVID-19 Revenue by Type (2023-2028) & (USD Million)

Table 91. Middle East & Africa Biologic Medication in COVID-19 Revenue by Application (2017-2022) & (USD Million)

Table 92. Middle East & Africa Biologic Medication in COVID-19 Revenue by Application (2023-2028) & (USD Million)

Table 93. Middle East & Africa Biologic Medication in COVID-19 Revenue by Country (2017-2022) & (USD Million)

Table 94. Middle East & Africa Biologic Medication in COVID-19 Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Biologic Medication in COVID-19 Picture

Figure 2. Global Biologic Medication in COVID-19 Revenue Market Share by Type in 2021

Figure 3. Neutralizing Antibodies

Figure 4. Anti-inflammatory Drugs

Figure 5. Biologic Medication in COVID-19 Revenue Market Share by Application in 2021

Figure 6. COVID-19 Picture

Figure 7. Influenza Picture

Figure 8. Malaria Picture

Figure 9. Others Picture

Figure 10. Global Biologic Medication in COVID-19 Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Biologic Medication in COVID-19 Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Biologic Medication in COVID-19 Revenue Market Share by Region (2017-2028)

Figure 13. Global Biologic Medication in COVID-19 Revenue Market Share by Region in 2021

Figure 14. North America Biologic Medication in COVID-19 Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Biologic Medication in COVID-19 Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Biologic Medication in COVID-19 Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Biologic Medication in COVID-19 Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Biologic Medication in COVID-19 Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Biologic Medication in COVID-19 Market Drivers

Figure 20. Biologic Medication in COVID-19 Market Restraints

Figure 21. Biologic Medication in COVID-19 Market Trends

Figure 22. Roche Recent Developments and Future Plans

Figure 23. Sanofi Recent Developments and Future Plans

Figure 24. Novartis Recent Developments and Future Plans

Figure 25. Merck Recent Developments and Future Plans

Figure 26. Bayer Recent Developments and Future Plans

Figure 27. Shutaishen Recent Developments and Future Plans

Figure 28. Biogen Recent Developments and Future Plans

Figure 29. Regeneron Pharmaceuticals Recent Developments and Future Plans

Figure 30. Vir Biotech Recent Developments and Future Plans

Figure 31. Junshi Biosciences Recent Developments and Future Plans

Figure 32. Anke Biotechnology Recent Developments and Future Plans

Figure 33. OncoImmune Recent Developments and Future Plans

Figure 34. Global Biologic Medication in COVID-19 Revenue Share by Players in 2021

Figure 35. Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Biologic Medication in COVID-19 Revenue Market Share in 2021

Figure 37. Global Top 10 Players Biologic Medication in COVID-19 Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Biologic Medication in COVID-19 Revenue Share by Type in 2021

Figure 40. Global Biologic Medication in COVID-19 Market Share Forecast by Type (2023-2028)

Figure 41. Global Biologic Medication in COVID-19 Revenue Share by Application in 2021

Figure 42. Global Biologic Medication in COVID-19 Market Share Forecast by Application (2023-2028)

Figure 43. North America Biologic Medication in COVID-19 Sales Market Share by Type (2017-2028)

Figure 44. North America Biologic Medication in COVID-19 Sales Market Share by Application (2017-2028)

Figure 45. North America Biologic Medication in COVID-19 Revenue Market Share by Country (2017-2028)

Figure 46. United States Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Biologic Medication in COVID-19 Sales Market Share by Type (2017-2028)

Figure 50. Europe Biologic Medication in COVID-19 Sales Market Share by Application (2017-2028)

Figure 51. Europe Biologic Medication in COVID-19 Revenue Market Share by Country (2017-2028)

Figure 52. Germany Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Biologic Medication in COVID-19 Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Biologic Medication in COVID-19 Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Biologic Medication in COVID-19 Revenue Market Share by Region (2017-2028)

Figure 60. China Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Biologic Medication in COVID-19 Sales Market Share by Type (2017-2028)

Figure 67. South America Biologic Medication in COVID-19 Sales Market Share by Application (2017-2028)

Figure 68. South America Biologic Medication in COVID-19 Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Biologic Medication in COVID-19 Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Biologic Medication in COVID-19 Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Biologic Medication in COVID-19 Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Biologic Medication in COVID-19 Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source